Teva Pharmaceutical Industries (TEVA) R&D US GAAP (year values) |
|||||||||
2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
R&D, bln rub | 1 010 | 997.0 | 967.0 | 838.0 | 953.0 | 949.0 | |||
Changes by years, y/y, % | -17% | -1% | -3% | -13% | +14% | -4.7% |
Teva Pharmaceutical Industries. R&D, bln rub
Teva Pharmaceutical Industries. R&D, changes, %
Teva Pharmaceutical Industries. R&D, sum by quarters, bln rub
Teva Pharmaceutical Industries (TEVA) R&D US GAAP (quarter values) |
||||||||
2023Q2 | 2023Q3 | 2023Q4 | 2023Q4 | 2024Q1 | LTM ? | |||
R&D, bln rub | 240.0 | 253.0 | 227.0 | 227.0 | 242.0 | 949.0 | ||
Changes by years, y/y, % | +5% | +45% | +8% | +8% | +3% | |||
Changes by quarters, q/q, % | +3% | +5% | -10% | 0% | +7% |